(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 39.54%-905.4K | -33.86%-4.34M | 72.32%-223.52K | -70.27%-1.76M | -21.18%-861.32K | -116.36%-1.5M | 40.22%-3.24M | 5.32%-807.41K | 36.83%-1.03M | 59.71%-710.78K |
Net income from continuing operations | 24.59%-750.62K | -34.88%-5.48M | -45.14%-1.82M | -21.29%-1.58M | -25.12%-1.08M | -55.60%-995.38K | 34.11%-4.06M | -53.15%-1.26M | 43.71%-1.31M | 51.75%-861.1K |
Asset impairment expenditure | ---- | --795.53K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Remuneration paid in stock | 1,048.58%182.45K | -26.79%286.22K | 757.95%270.33K | --0 | --0 | --15.89K | -36.61%390.94K | 159.28%31.51K | -45.19%359.43K | --0 |
Change In working capital | 34.90%-337.23K | -87.16%54.85K | 27.93%533.37K | -101.72%-176.63K | 43.78%216.13K | -888.04%-518.02K | 251.41%427.24K | 1,946.62%416.92K | -421.69%-87.56K | 825.15%150.32K |
-Change in receivables | 95.73%-8.42K | -24.03%29.68K | 1,627.00%156.52K | 104.73%1.78K | -35.74%68.68K | -889.02%-197.29K | -81.35%39.07K | -121.66%-10.25K | -154.66%-37.6K | 1,424.13%106.87K |
-Change in payables and accrued expense | -2.52%-328.81K | -93.52%25.16K | -11.78%376.85K | -257.08%-178.41K | 239.38%147.45K | -887.44%-320.73K | 541.41%388.17K | 1,684.92%427.17K | -219.00%-49.96K | 370.41%43.45K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 39.54%-905.4K | -33.86%-4.34M | 72.32%-223.52K | -70.27%-1.76M | -21.18%-861.32K | -116.36%-1.5M | 40.22%-3.24M | 5.32%-807.41K | 36.83%-1.03M | 59.71%-710.78K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -385.58K | 54.80%-336.95K | 93.41%-37.65K | -35.57%-60.97K | -120.88%-238.32K | 0 | 14.14%-745.42K | 24.48%-571.59K | -7.68%-44.98K | -70.92%-107.9K |
Net PPE purchase and sale | ---385.58K | 54.80%-336.95K | 93.41%-37.65K | -35.57%-60.97K | -120.88%-238.32K | --0 | 14.14%-745.42K | 24.48%-571.59K | -7.68%-44.98K | -70.92%-107.9K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---385.58K | 54.80%-336.95K | 93.41%-37.65K | -35.57%-60.97K | -120.88%-238.32K | --0 | 14.14%-745.42K | 24.48%-571.59K | -7.68%-44.98K | -70.92%-107.9K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -60.58%1.85M | 4.68M | 0 | 0 | 0 | 4.68M | 0 | 0 | 0 | 0 |
Net common stock issuance | -60.20%1.99M | --5M | --0 | --0 | --0 | --5M | --0 | --0 | --0 | --0 |
Net other financing activities | 54.62%-144.7K | ---318.85K | --0 | --0 | --0 | ---318.85K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -60.58%1.85M | --4.68M | --0 | --0 | --0 | --4.68M | --0 | --0 | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | 7.30%22.17K | -99.48%20.66K | -79.76%283.35K | -15.08%2.1M | -2.82%3.2M | -99.48%20.66K | -59.92%4.01M | -75.09%1.4M | -66.04%2.48M | -62.64%3.3M |
Current changes in cash | -82.59%554.32K | 100.04%1.51K | 81.06%-261.18K | -68.83%-1.82M | -34.32%-1.1M | 546.45%3.18M | 33.46%-3.99M | 14.33%-1.38M | 35.73%-1.08M | 46.39%-818.68K |
End cash Position | -82.01%576.49K | 7.30%22.17K | 7.30%22.17K | -79.76%283.35K | -15.08%2.1M | -2.82%3.2M | -99.48%20.66K | -99.48%20.66K | -75.09%1.4M | -66.04%2.48M |
Free cash from | 13.79%-1.29M | -17.30%-4.68M | 81.06%-261.18K | -68.83%-1.82M | -34.32%-1.1M | -110.00%-1.5M | 36.63%-3.99M | 14.33%-1.38M | 35.73%-1.08M | 55.19%-818.68K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.